Sofinnova Investments Overview

  • Investor Type

  • Venture Capital

  • Status

  • Active

  • Professionals

  • 22

Professionals
  • Investments

  • 290

  • Portfolio

  • 28

  • Exits

  • 194

Exits

Sofinnova Investments General Information

Description

Founded in 1974, Sofinnova Investments is a venture capital firm headquartered in Menlo Park, California. The firm seeks to invest in the life science sector United States and Europe.

Contact Information

Website
www.sofinnova.com
Year Founded
1974
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
PE/Buyout
Primary Office
  • 3000 Sand Hill Road, Building 4
  • Suite 250
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000

Sofinnova Investments Investments (290)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
RayzeBio 13-Sep-2022 Later Stage VC 00000 Drug Discovery Clinical Trials - General 0000 000000 00.0
00000000 000000000 17-Dec-2021 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 0000 000000 00.0
0000000 0000000000 16-Nov-2021 00000 00000 0000 Drug Discovery Out of Business 00000 00000000 00.0
000000 00000000000 02-Nov-2021 00000 00000 0000 Drug Discovery Generating Revenue 00000 00000000 00.0
000000 00000000000 26-Oct-2021 00000 00000 0000 Biotechnology Pre-Clinical Trials 0000 000000 00.0
000000 000000 22-Sep-2021 00000 00000 00000 Drug Discovery Generating Revenue/Not Profitable 00000 00000 00.0
00000000 21-May-2021 00000 00000 Industrial Supplies and Parts Generating Revenue
000000000 26-Mar-2021 00000 00000 00000 Drug Discovery Clinical Trials - Phase 2 0000 000000 00.0
XyloCor Therapeutics 20-Jan-2021 Later Stage VC 000.00 Biotechnology Clinical Trials - Phase 2 00000 00000 00
Vera Therapeutics 19-Jan-2021 Later Stage VC 0000 Drug Discovery Generating Revenue/Not Profitable 0000 000000 00.0
You’re viewing 10 of 290 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sofinnova Investments Exits (194)

Company Name Exit Date Exit Type Exit Size
Neurana Pharmaceuticals 18-Oct-2022 Out of Business
000000 000000 12-Aug-2022 000000 0000000000 00000
000000000 00000000 31-May-2022 000000000000000000 00000
000000000 17-Feb-2022 000000000000000000 00.00
0000 000000000000 11-Feb-2022 000000 0000000000 000.00
000000 000000 07-Jan-2022 000 00000
000000000 000 15-Dec-2021 000 00 00000000
000000000 16-Nov-2021 000000000000000000
Dauntless Pharmaceuticals 27-Oct-2021 Out of Business
Clariteam 01-Oct-2021 Secondary Transaction - Private
You’re viewing 10 of 194 exits. Get the full list »

Sofinnova Investments Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Sofinnova Investments‘s full profile, request access.

Request a free trial

Sofinnova Investments Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Sofinnova Investments Team (66)

Name Title Deals Funds Boards Office
James Healy MD Managing Partner 00 0 00 Menlo Park, CA
Lars Ekman Ph.D Executive Partner, Private Equity 0 0 0 Menlo Park, CA
David Kabakoff Ph.D Executive Partner, Private Equity 00 0 0 Menlo Park, CA
Nathalie Auber Partner, Chief Financial Officer & Board Member Menlo Park, CA
Eric Delbridge MD Portfolio Manager & Partner, Public Equity Menlo Park, CA
You’re viewing 5 of 66 team members. Get the full list »

Sofinnova Investments Co-Investors (139)

Name With Exits Lead Partner Series Industry
Citadel Enterprise Americas 6 0 0 Series chart Industry bar
Longitude Capital 0 0 0 Series chart Industry bar
Novo Holdings 0 0 0 Series chart Industry bar
RA Capital Management 0 0 Series chart Industry bar
venBio 0 0 0 Series chart Industry bar
You’re viewing 5 of 139 co-investors. Get the full list »